Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery

October 8, 2018 updated by: Caitin Conley, University of Kentucky

Effects of a Superimposed Electrical Stimulation Knee Garment on Strength, Function, Inhibition, Cortical Excitability, and Patient Reported Outcomes After Knee Surgery

The purpose of this study is to determine if a home-based electrical stimulation (ES) program is more effective than the standard of care (SOC) at improving quadriceps function, functional outcomes, patient reported outcomes, and treatment compliance in patients recovering from knee surgery. It is hypothesized that there will be significantly better outcomes and compliance in ES group when compared to the SOC group.

Study Overview

Detailed Description

The purpose of this study is to evaluate the effect of home-based neuromuscular electrical stimulation applied via a knee sleeve on strength, function, inhibition, and patient reported outcomes. Strength will be evaluated via isometric knee extension, neuromuscular inhibition will be assessed via a superimposed burst technique, and cortical excitability will be assessed via transcranial magnetic stimulation. In addition, we will evaluate function through a single-leg hop task, star excursion balance test, and a step down task. Patient reported outcomes will be assessed via the: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale.

Once a participant is identified as eligible and consents to enroll in the study, they will be allocated to either an intervention or control group. The participants in the intervention group will receive a knee sleeve that has a neuromuscular ES unit embedded into the garment (EMPI Phoenix, DJO Global, Vista, California) in addition to SOC. A superimposed electrical signal (maximal toleration) will be utilized during treatment in order to successfully overload the muscle. During the electrical stimulation the participants will be instructed to perform an isometric contraction and hold this contraction through the length of the stimulation. Beginning one week post-operatively the participants will be instructed to perform NMES treatment 3 times a day for 20 minutes 5 times a week for 12 weeks. The stimulation will be delivered at a frequency of 75Hz with a duty cycle of 4 seconds on and 10 seconds off. The control group will be treated with the current SOC, performing a home-based treatment of volitional isometrics contractions without the addition of neuromuscular electrical stimulation beginning on the third day post-operatively. Participants will perform 20 isometric contractions holding each contraction for 10 seconds 3 times a day 5 times a week for 12 weeks. Participants will be instructed to keep a treatment log documenting at each session how many exercises and at what intensity they performed.

Study Type

Observational

Enrollment (Actual)

87

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40506
        • University of Kentucky Musculoskeletal Laboratory
      • Lexington, Kentucky, United States, 40517
        • University of Kentucky Orthopaedics and Sports Medicine Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 60 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients from the University of Kentucky Orthopaedics and Sports Medicine Clinic who are seeking surgical treatment for a disease/injury of the knee.

Description

Inclusion Criteria:

  • Must be scheduled for surgery to address pain, injury, or dysfunction of the knee joint.
  • Must be able to communicate using the English language

Exclusion Criteria:

  • Previous surgery to the contralateral ankle, hip, or knee
  • Injury to the hip, ankle, or contralateral knee in the past six months
  • Currently being treated for low back pain
  • Presence of a heart condition/pacemaker
  • History and/or family history of seizures/epilepsy
  • Vestibular or other balance disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric knee extension torque
Time Frame: Preoperative baseline, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Knee extension torque derived from a maximal voluntary isometric contraction
Preoperative baseline, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Quadriceps activation
Time Frame: Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Central activation ratio of the quadriceps derived from the superimposed burst technique
Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported outcomes
Time Frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Patient-reported outcome measures will include the following: Veterans Rand 12 Item Health Survey (VR-12), Knee Osteoarthritis Outcomes Score (KOOS), the International Cartilage Repair Society (ICRS), the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, and the Lysholm scale
Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Functional outcomes
Time Frame: Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Functional outcome measures will include the following: Single-leg hop, 30-second step down, and star-excursion balance test.
Preoperative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Cortical excitability
Time Frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
Individuals who have been diagnosed with epilepsy or have a family history of epilepsy may be at risk of seizure during cortical excitability testing. Therefore, these individuals will be excluded from this study. Otherwise, this measure is considered to be safe and is used in the realms of both medicine and research.
Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment compliance
Time Frame: Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative
The number and duration of treatments performed by the patients
Preoperative, 1 month post-operative, 3-4 month post-operative, 6 month post-operative, and 12 month post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Conrad M Gabler, PhD, ATC, University Of Kentucky
  • Principal Investigator: Caitlin E Whale Conley, PhD, ATC, University Of Kentucky
  • Study Chair: Carl G Mattacola, PhD, ATC, University Of Kentucky

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2014

Primary Completion (ACTUAL)

May 1, 2017

Study Completion (ACTUAL)

October 1, 2018

Study Registration Dates

First Submitted

February 6, 2014

First Submitted That Met QC Criteria

February 6, 2014

First Posted (ESTIMATE)

February 10, 2014

Study Record Updates

Last Update Posted (ACTUAL)

October 9, 2018

Last Update Submitted That Met QC Criteria

October 8, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 13-0776-F2L

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-operative Quadriceps Weakness

Subscribe